Scinai Biopharma Services

Scinai Biopharma is a biopharmaceutical company focused on developing a proprietary pipeline of alpaca-derived NanoAb (VHH-antibody) therapies for inflammation and infectious diseases. The company operates a specialized business unit, Scinai Biopharma Services, which functions as a boutique CDMO providing end-to-end drug development and cGMP manufacturing services for biologics. Their lead internal candidate is an inhaled COVID-19 treatment designed for local neutralization of the virus. By leveraging its state-of-the-art facility in Jerusalem, Scinai supports both its internal pipeline and external clients in the biotech industry with process development and clinical-scale production.